Quarterly report pursuant to Section 13 or 15(d)

Net Income (Loss) Per Share (Antidilutive Securities) (Details)

v3.10.0.1
Net Income (Loss) Per Share (Antidilutive Securities) (Details) - shares
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Common share equivalents for securities that were anti-dilutive and therefore excluded from the computation of diluted earnings per share        
Anti-dilutive securities excluded from computation of diluted loss per share (in shares) 7,793,826 7,311,730 7,793,826 7,311,730
Stock options        
Common share equivalents for securities that were anti-dilutive and therefore excluded from the computation of diluted earnings per share        
Anti-dilutive securities excluded from computation of diluted loss per share (in shares) 0 2,667,329 0 2,667,329
Unvested restricted stock units and awards        
Common share equivalents for securities that were anti-dilutive and therefore excluded from the computation of diluted earnings per share        
Anti-dilutive securities excluded from computation of diluted loss per share (in shares) 0 1,901,080 0 1,901,080
Convertible Notes        
Common share equivalents for securities that were anti-dilutive and therefore excluded from the computation of diluted earnings per share        
Anti-dilutive securities excluded from computation of diluted loss per share (in shares) 7,793,826 2,743,321 7,793,826 2,743,321